FDA Finalizes New Systematic Review Process for Food Chemical Safety
The FDA is changing how it looks at food chemicals after they are already in the food supply. The agency has finalized a new systematic process for post-market safety reviews, a move meant to make chemical reassessments more consistent, transparent, and science-based.
The U.S. Food and Drug Administration also announced that it has started reassessments of two common food additives: butylated hydroxytoluene, known as BHT, and azodicarbonamide, known as ADA.
The step matters because many food chemicals were approved or accepted years ago. Science changes. Diets change. Manufacturing changes. A post-market review process gives the agency a clearer path for deciding when older safety decisions need another look.
The FDA’s new process focuses on chemicals already in the food supply
The finalized approach gives FDA staff a structured way to identify, prioritize, and assess food chemicals after they have entered the market.
That is different from pre-market review, where the agency evaluates certain substances before manufacturers use them in food. Post-market review deals with what happens later, when new research becomes available or when exposure patterns shift.
Food chemicals can include:
Food additives
Color additives
Food contact substances
Substances considered generally recognized as safe, often called GRAS
Contaminants that may enter food through processing, packaging, or the environment
The new process is meant to help the FDA decide which substances need attention first. That can include chemicals with new safety data, chemicals that consumers may be exposed to more often than expected, or chemicals that raise questions because of new scientific methods.
A central part of the process is prioritization. The agency cannot reassess every food chemical at once, so it needs a way to sort issues by possible public health concern.
The process also gives the public and industry a clearer view of how FDA scientists move from an initial signal to a full safety review. In practice, that means the agency can better explain why it selected one chemical for review and not another.
Why post-market reviews have become more important
Food safety decisions do not stand still.
A substance that was reviewed decades ago may have been evaluated using older data, older toxicology methods, or older assumptions about how much people consume. Since then, food habits may have changed. A chemical may appear in more food categories. New studies may suggest different questions than researchers asked at the time of the original review.
That does not mean older approvals are automatically unsafe. It means the safety question may need to be checked again.
The FDA’s move reflects a broader shift in food regulation. Agencies are under growing pressure to show how they track substances already in commerce, not only how they approve new ones.
Post-market review can help answer several practical questions:
Has exposure to a chemical increased?
Are some groups, such as children, more exposed than expected?
Do newer studies raise concerns that earlier reviews did not address?
Are current approved uses still supported by the evidence?
Should labels, specifications, use limits, or authorizations change?
The new process also gives industry a clearer signal. Food companies may need better records, stronger supplier controls, and a better understanding of which additives appear in their products.
For consumers, the change may make FDA decisions easier to follow. Instead of reassessments appearing as one-off actions, the agency is trying to set a repeatable system.
The first reassessments under the spotlight are BHT and ADA
Alongside the finalized process, the FDA has launched reassessments of BHT and ADA, two additives that have been used in different parts of the food system.
The start of a reassessment does not mean the FDA has decided either additive is unsafe. It means the agency is taking a fresh look at the available science, exposure information, and current uses.
BHT is used to help preserve fats and oils
BHT, or butylated hydroxytoluene, is an antioxidant. In food, antioxidants can help slow rancidity in products that contain fats or oils.
BHT has been used in some packaged foods, including certain cereals, snack foods, and other shelf-stable products. Its role is not to add flavor or nutrition. It helps protect product quality during storage.
A reassessment of BHT may look at questions such as:
How widely BHT is used today
How much BHT different groups may consume
What newer toxicology research shows
Whether existing use limits remain appropriate
Whether certain food categories need closer review
The FDA will need to weigh both hazard and exposure. A substance can raise questions in a lab study, but the regulatory decision also depends on how much people actually consume and under what conditions.
That distinction matters. Food chemical reviews are not based only on whether a substance can cause harm at some dose. They also ask what level of exposure occurs in real diets.
ADA is used in some flour and bread products
ADA, or azodicarbonamide, has been used as a dough conditioner and flour treatment agent. In food production, such additives can affect dough handling and baking performance.
ADA is also known outside food because it has industrial uses, which has drawn public attention over the years. That fact alone does not answer the food safety question, but it has made ADA one of the more recognizable food additive names.
A reassessment of ADA may examine:
Current use in flour and baked goods
Consumer exposure from food uses
Data on ADA and breakdown products
Whether food uses remain within safety limits
Whether alternatives are already common in the marketplace
Some manufacturers have removed ADA from products over time in response to consumer concern or retailer standards. The FDA review will focus on the safety of permitted uses, not on marketing preferences.
What the new review process is likely to include
The FDA has described the new approach as systematic, which means reviews should move through defined phases rather than ad hoc decisions.
While the details can vary by substance, a post-market safety review usually depends on several types of information.
Review area | Why it matters |
Use information | Shows where and how a chemical appears in food |
Exposure estimates | Helps assess how much people may consume |
Toxicology data | Identifies possible health effects and safe intake levels |
Vulnerable groups | Checks whether children or other groups may have higher exposure |
Manufacturing data | Helps confirm purity, specifications, and actual use levels |
Public input | Gives researchers, companies, and consumers a chance to share information |
The FDA can use these reviews to decide whether no action is needed, more data are needed, or risk management steps are appropriate.
Possible outcomes could include revised use levels, updated specifications, new guidance, changes to authorizations, or other regulatory steps. The agency may also determine that the current evidence supports continued use under existing conditions.
A key feature of the new process is that it should help the FDA explain its reasoning. That matters because food chemical debates can become confusing quickly. Without a clear review structure, the public may not know whether a concern is based on new science, changing exposure, public pressure, or all three.
Transparency will be a major test
The FDA’s new process will be judged not only by how it is written, but by how it works in practice.
Food chemical safety is a high-interest subject because it sits at the intersection of science, regulation, and trust. Consumers often see unfamiliar ingredient names and want clear answers. Manufacturers need predictable rules. Public health groups want faster action when evidence changes.
For the process to build confidence, the agency will need to communicate plainly about:
Why a chemical was selected for reassessment
What data the agency is relying on
What uncertainties remain
How the FDA estimates exposure
When the public can provide information
What decision comes next
Clear communication is especially important when the science is mixed. One study may point to a possible hazard, while other data may show low exposure or limited relevance to food uses. A good review process has to explain how the agency handles those differences.
The FDA also faces a speed challenge. Scientific review takes time, but public concern can move faster than agency timelines. A systematic process may help by making the queue and criteria clearer, but it will not remove the hard work of gathering data and weighing evidence.
What food companies should watch now
The reassessments of BHT and ADA may be the first visible examples of how the new process works.
Companies that use either additive, or ingredients that may contain them, should be prepared to understand their supply chains. That includes knowing where the additive appears, at what levels, and for what technical purpose.
Even companies that do not use BHT or ADA may want to pay attention. The new process signals that other food chemicals could face future review as the FDA sorts priorities.
Practical steps for food manufacturers may include:
Reviewing ingredient specifications
Checking supplier documentation
Confirming actual use levels
Tracking public FDA notices and comment opportunities
Evaluating available alternatives
Keeping records that support safety and compliance
The process may also affect product development. If a company chooses to use an older additive, it may face more questions from retailers, consumers, or regulators. Clear documentation can help answer those questions.
At the same time, replacing an additive is not always simple. An alternative must work in the product, meet safety standards, preserve quality, and avoid creating new issues. Reformulation can affect shelf life, texture, cost, and food waste.
What consumers should take from the announcement
For consumers, the main point is simple: the FDA is creating a more formal way to revisit food chemical safety after products are already on the market.
That is a meaningful change, but it is not a same-day verdict on BHT, ADA, or any other additive.
The reassessments will likely take time. They may involve scientific papers, exposure modeling, use data from industry, public comments, and internal FDA analysis. The results could range from no change to new limits or other regulatory action.
People who want to reduce exposure to certain additives can read ingredient labels and compare products. BHT and ADA, when used in packaged foods, should appear in ingredient lists under their names or accepted naming formats. Many food makers already market products without certain additives, so alternatives may be available in some categories.
Still, ingredient names alone do not tell the full safety story. A long chemical name is not automatically dangerous, and a familiar name is not automatically safe. The FDA’s review process is meant to look beyond impressions and focus on evidence.
The bigger shift is toward ongoing oversight
The FDA’s finalized systematic review process marks a broader change in how food chemical safety is managed in the United States.
Instead of treating safety review as a one-time event, the agency is building a framework for ongoing oversight. That fits the reality of food science. New data appear. New uses develop. Eating patterns shift. Analytical tools improve.
BHT and ADA will now help show how the process works outside the policy document. Their reassessments will be watched by industry, consumer groups, scientists, and state regulators.
The key question is whether the FDA can turn the new framework into timely, clear, and credible decisions. If it can, the process could make food chemical oversight easier to understand and easier to trust.
This article is for informational purposes only and is not legal, regulatory, or medical advice. For companies affected by food additive rules, qualified regulatory counsel or food safety experts can provide guidance based on specific products and uses.
Comments